Home › Trial NCT00112827
Melphalan and Radiation Therapy Followed By Lenalidomide in Treating Patients Who Are Undergoing Autologous Stem Cell Transplant for Stage I, Stage II, or Stage III Multiple Myeloma
- Trial IDNCT00112827
- StatusCompleted
- PhasePhase 1/2
- Study typeInterventional
- SponsorCity of Hope Medical Center
- Enrollment54
- Start date2004-11
- ConditionsRefractory Multiple Myeloma · Smoldering Multiple Myeloma · Stage I Multiple Myeloma · Stage II Multiple Myeloma · Stage III Multiple Myeloma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.